That, my friend, is the billion dollar question.
I'm still thinking it's good FDA news, but I would have loved to see an early approval.
And I think it's mostly priced in. But as a long-term holder, I'll be happy to see a big sell-the-news situation as a good buying opportunity.
What do you think?
Ann: NCCN Guidelines updated to include PSMA-PET Imaging, page-7
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.80 |
Change
0.320(1.83%) |
Mkt cap ! $5.956B | |||
| Open | High | Low | Value | Volume |
| $17.83 | $17.88 | $17.43 | $15.18M | 856.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2418 | $17.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.80 | 18320 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| TLX (ASX) Chart |